Incidence and cost of pneumonia in medicare beneficiaries.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chest

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.11-1160PMID 22406959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Summary of notifiable diseases -- United States, 2010

  2012cited by this paper
• One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.

  2011cited by this paper
• Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia.

  2011cited by this paper
• Recommended Adult Immunization Schedule: United States, 2011*

  2011cited by this paper
• Healthcare utilization and cost of pneumococcal disease in the United States.

  2011cited by this paper
• Recommended adult immunization schedule--United States, 2011.

  2011cited by this paper
• Burden of Community-Acquired Pneumonia in North American Adults

  2010cited by this paper
• Propensity score methods.

  2010cited by this paper
• Current Perspective of the HCAP Problem: Is It CAP or Is It HAP?

  2009cited by this paper
• Propensity scores and M‐structures

  2009cited by this paper
• Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.

  2009cited by this paper
• Remarks on the method of propensity score

  2009cited by this paper
• Administrative and Claims Records as Sources of Health Care Cost Data

  2009cited by this paper
• Pneumonia in the Elderly: A Review of Severity Assessment, Prognosis, Mortality, Prevention, and Treatment

  2008cited by this paper
• Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

  2008cited by this paper
• Predictors of length of stay between the young and aged in hospitalized community‐acquired pneumonia patients

  2008cited by this paper
• Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

  2007cited by this paper
• Case-mix adjustment for an expanded renal prospective payment system.

  2007cited by this paper
• Influence of Comorbid Conditions on Long‐Term Mortality After Pneumonia in Older People

  2007cited by this paper
• The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials

  2007cited by this paper
• International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia.

  2007cited by this paper
• Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience

  2007cited by this paper
• Too much ado about propensity score models? Comparing methods of propensity score matching.

  2006cited by this paper
• Accuracy of Administrative Data for Identifying Patients With Pneumonia

  2005cited by this paper
• Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.

  2005cited by this paper
• On principles for modeling propensity scores in medical research

  2004cited by this paper
• The Burden of Community-Acquired Pneumonia in Seniors: Results of a Population-Based Study

  2004cited by this paper
• Hospital readmissions of elderly patients hospitalized with pneumonia.

  2003cited by this paper
• Pneumonia: still the old man's friend?

  2003cited by this paper
• Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

  2002cited by this paper
• Estimating the causal effects of smoking

  2001cited by this paper
• Pneumonia in the elderly.

  2001cited by this paper
• The Period Prevalence and Costs of Treating Nonmelanoma Skin Cancers in Patients Over 65 Years of Age Covered by Medicare

  2001cited by this paper
• American College of Clinical Pharmacology Response to the Institute of Medicine Report “To Err Is Human: Building a Safer Health System”

  2000cited by this paper
• Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95

  2000cited by this paper
• Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies.

  1999cited by this paper
• Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study.

  1999cited by this paper
• Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.

  1999cited by this paper
• The Cost of Treating Patients with Community-Acquired Pneumonia

  1999cited by this paper
• The cost of treating community-acquired pneumonia.

  1998cited by this paper
• Community-Acquired Pneumonia: Can It Be Defined with Claims Data?

  1997cited by this paper
• Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.

  1997cited by this paper
• Incidence of Community-Acquired Pneumonia Requiring Hospitalization Results of a Population-Based Active Surveillance Study in Ohio

  1997cited by this paper
• Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia.

  1993cited by this paper
• Pneumonia—The Quality of Medical Records Data

  1987cited by this paper
• Health: United States

  1986cited by this paper
• Population Marginal Means in the Linear Model: An Alternative to Least Squares Means

  1980cited by this paper

• Association between the geriatric nutritional risk index and all-cause mortality in older critically ill patients with community-acquired pneumonia

  2025cites this paper
• Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLISH)

  2025cites this paper
• Consistency between metagenomic next-generation sequencing versus traditional microbiological tests for infective disease: systemic review and meta-analysis

  2025cites this paper
• The clinical value of mNGS of bronchoalveolar lavage fluid versus traditional microbiological tests for pathogen identification and prognosis of severe pneumonia (NT-BALF):study protocol for a prospective multi-center randomized clinical trial

  2024cites this paper
• Heparin-binding protein combined with human serum albumin in early assessment of community-acquired pneumonia: A retrospective study

  2023cites this paper
• Does Dysphagia Predict Inpatient Morbidity and Mortality in Geriatric Patients Admitted for Aspiration Pneumonia?

  2023cites this paper
• Pneumonia is not just pneumonia: Differences in utilization and costs with common comorbidities.

  2023cites this paper
• Identifying Risk Factors for Aspiration in Patients Hospitalized with Community-Acquired Pneumonia

  2023cites this paper
• Costs of management of acute respiratory infections in older adults: A systematic review and meta-analysis

  2022cites this paper
• Silencing of long non-coding RNA H19 alleviates lipopolysaccharide (LPS)-induced apoptosis and inflammation injury by regulating miR-140-5p/TLR4 axis in cell models of pneumonia.

  2022cites this paper
• Prognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department

  2022cites this paper
• Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US

  2021cites this paper
• Пневмония

  2021cites this paper
• Efficacy of Chinese Herbal Injections for Elderly Patients With pneumonia—A Bayesian Network Meta-analysis of Randomized Control Trials

  2021cites this paper
• LncRNA PFAL suppresses TNF-α-induced inflammation by upregulating miR-18a in WI-38 cells

  2021cites this paper
• rs1840680 single nucleotide polymorphism in Pentraxin 3: a potential protective biomarker of severe community-acquired pneumonia

  2021cites this paper
• Risk-Standardized Home Time as a Novel Hospital Performance Metric for Pneumonia Hospitalization Among Medicare Beneficiaries: a Retrospective Cohort Study

  2021cites this paper
• The influence of diabetes on postoperative complications following colorectal surgery

  2021cites this paper
• Prognostic factors in nursing and healthcare-associated pneumonia.

  2020cites this paper
• Short-term exposure to fine particulate matter and pneumonia-related hospitalizations: a systematic review and meta-analysis

  2020cites this paper
• Attributable Cost of Adult Hospitalized Pneumonia Beyond the Acute Phase

  2020cites this paper
• Desempeño del SOAR como predictor de severidad de la neumonía adquirida en la comunidad

  2020cites this paper
• A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia☆☆☆☆☆☆

  2020cites this paper
• Tetrahydropyrimidines, ZL-5015 Alleviated Lipopolysaccharide (LPS)-Induced Acute Pneumonia in Rats by Activating the NRF-2/HO-1 Pathway

  2020cites this paper
• Prevalence of gram negative bacteria causing community acquired pneumonia among adults in Mwanza City, Tanzania

  2020cites this paper
• Financial Risk for COVID-19–like Respiratory Hospitalizations in Consumer-Directed Health Plans

  2020cites this paper
• Kidney injury induced by elevated histones in community-acquired pneumonia

  2020cites this paper
• Implementation of Real-Time Electronic Clinical Decision Support for Emergency Department Patients with Pneumonia Across a Healthcare System

  2020cites this paper
• Neutrophil Gelatinase-Associated Lipocalin for Predicting Intensive Care Unit Admission and Mortality in Patients with Pneumonia.

  2020cites this paper
• The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study

  2020cites this paper
• Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study

  2019cites this paper
• Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer

  2019cites this paper
• Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials

  2019cites this paper
• Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia

  2019cites this paper
• Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia

  2019cites this paper
• Age-Related Dysfunction in the Innate Immune Response to Lung Infections

  2019cites this paper
• Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis

  2019cites this paper
• NACHT, LRR, and PYD domains-containing Protein 3 and LL-37: prognostic value of new biomarkers in community-acquired pneumonia

  2019cites this paper
• The Epidemiology of Hospitalized Pneumonia in Bahteramas Hospital, Southeast Sulawesi Province

  2019cites this paper
• Thirty-day Spending and Outcomes for an Episode of Pneumonia Care Among Medicare Beneficiaries.

  2019cites this paper
• The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA.

  2019cites this paper
• Rates of hospitalization for community-acquired pneumonia among US adults: A systematic review.

  2019cites this paper
• Consequences of Pneumonia in Older Adults

  2019cites this paper
• A BioHackathon on the challenges of aging: Rapid need-finding and solution modeling in a student-led event

  2019cites this paper
• Identification of potential key genes associated with severe pneumonia using mRNA-seq

  2018cites this paper
• Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial

  2018cites this paper
• Decision-making for PCV in adults

  2018cites this paper
• Etiology of community-acquired pneumonia in Western Australian metropolitan hospitals: Missed opportunities for pneumococcal vaccination

  2018cites this paper
• Long noncoding RNA HAGLROS regulates cell apoptosis and autophagy in lipopolysaccharides-induced WI-38 cells via modulating miR-100/NF-κB axis.

  2018cites this paper
• Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study

  2018cites this paper
• Creating a Protocol for Patient Outreach at a Primary Care Clinic

  2018cites this paper
• Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

  2018cites this paper
• Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community‐acquired pneumonia: A meta‐analysis

  2018cites this paper
• Feasibility of Providing Safe Mouth Care and Collecting Oral and Fecal Microbiome Samples from Nursing Home Residents with Dysphagia: Proof of Concept Study.

  2017influential citation
• Increasing pneumococcal vaccination among adults 65 and older: the development and implementation of a pneumococcal vaccine administration and documentation protocol for a small primary care practice.

  2017cites this paper
• Community-acquired pneumonia in Malawian adults: Aetiology and predictors of mortality.

  2017cites this paper
• Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network

  2017cites this paper
• Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective

  2017cites this paper
• Solithromycin: A novel ketolide antibiotic

  2017cites this paper
• Additional Cost Because of Pneumonia in Nursing Home Residents: Results From the Incidence of Pneumonia and Related Consequences in Nursing Home Resident Study.

  2017cites this paper
• Disease burden of hospitalized community-acquired pneumonia in South Korea

  2017cites this paper
• Hospital admissions by the oldest old: Past trends in one of the most ageing countries in the world

  2017cites this paper
• Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients.

  2017cites this paper
• РЕКУРРЕНТНЫЕ РЕСПИРАТОРНЫЕ ИНФЕКЦИИ У ДЕТЕЙ ПРИЧИНЫ, СВОЕВРЕМЕННАЯ ДИАГНОСТИКА, ЭФФЕКТИВНОЕ ЛЕЧЕНИЕ И ПРЕДОТВРАЩЕНИЕ РЕЦИДИВИРОВАНИЯ

  2017cites this paper
• Antimicrobial Therapy for Pneumonia in the Emergency Department: The Impact of Clinical Pharmacists on Appropriateness

  2017cites this paper
• Individual and health system variation in rehospitalizations the year after pneumonia

  2017cites this paper
• Innovation in Analysis of Respiratory Sounds

  2016cites this paper
• Pneumococcal conjugate vaccine use in adults

  2016cites this paper
• Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study

  2016cites this paper
• Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study

  2016cites this paper
• Community-acquired Pneumonia: A Global Perspective

  2016cites this paper
• Pneumonia Identification Using Nursing Home Records.

  2016cites this paper
• Identification of Potential Key Long Non-Coding RNAs and Target Genes Associated with Pneumonia Using Long Non-Coding RNA Sequencing (lncRNA-Seq): A Preliminary Study

  2016cites this paper
• The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study

  2016cites this paper
• Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspective

  2016cites this paper
• When is pneumonia not pneumonia: a clinicopathologic study of the utility of lung tissue biopsies in determining the suitability of cadaveric tissue for donation

  2016cites this paper
• Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States

  2016cites this paper
• Innate immune responses in the ageing lung

  2016cites this paper
• Do Corticosteroids Provide Benefit to Patients With Community-Acquired Pneumonia?

  2016cites this paper
• CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.

  2016cites this paper
• Validation of an administrative claims-based diagnostic code for pneumonia in a Us-based commercially insured COPD population inpatient

  2015cites this paper
• The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non–intensive care unit (ICU) hospital wards is complicated by the limited availability of evidence. We compared strategies of empirical treatment (allowing devi

  2015cites this paper
• Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia

  2015influential citation
• Diagnosis and Management of Recurrent Respiratory Tract Infections in Children: A Practical Guide

  2015cites this paper
• Antibiotic treatment strategies for community-acquired pneumonia in adults

  2015cites this paper
• New evidence prompts rethinking the clinical management of community acquired pneumonia in patients admitted to general medical services.

  2015cites this paper
• Health care and social care costs of pneumonia in Denmark: a register-based study of all citizens and patients with COPD in three municipalities

  2015cites this paper
• Erratum: Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases

  2015cites this paper
• Validation of an administrative claims-based diagnostic code for pneumonia in a Us-based commercially insured COPD population

  2015cites this paper
• The Impact of Patient Profiles and Procedures on Hospitalization Costs through Length of Stay in Community-Acquired Pneumonia Patients Based on a Japanese Administrative Database

  2015cites this paper
• Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population

  2015cites this paper
• Antibiotic treatment strategies for community-acquired pneumonia in adults.

  2015cites this paper
• Corticosteroids in the treatment of community-acquired pneumonia: an evidence summary.

  2015cites this paper
• Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis

  2014cites this paper
• Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases

  2014cites this paper
• Polybacterial human disease: the ills of social networking

  2014cites this paper
• Unexpected diagnosis of visceral leishmaniasis in a patient presenting with an infected ICD lead.

  2014cites this paper
• Implementation and Evaluation of an Oral Hygiene Program in Long-Term Care

  2014cites this paper
• Depression and risk of hospitalization for pneumonia in a cohort study of older Americans.

  2014cites this paper
• Predictors of rehospitalization after admission for pneumonia in the veterans affairs healthcare system.

  2014cites this paper